                         SEQUENCE LISTING

<110>  Novo Nordisk A/S
 
<120>  Prodrugs and uses thereof

<130>  200093WO01

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  31
<212>  PRT
<213>  Homo sapiens

<400>  1

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg Gly 
            20                  25                  30      


<210>  2
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Aib

<400>  2

His Xaa Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Arg Gly Arg Gly 
            20                  25                  30      


<210>  3
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Modified G

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Aib

<400>  3

Gly Xaa His Xaa Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu 
1               5                   10                  15      


Glu Gly Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Arg Gly Arg 
            20                  25                  30          


Gly 
    


<210>  4
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  4

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


